Abstracts Archive - Page 1606 of 2607 - ACR Meeting Abstracts

Abstract Number: 94 • 2016 ACR/ARHP Annual Meeting
Performance of the Patient Reported Outcomes Measurement Information System (PROMIS) Measure for Physical Function in Early RA
Till Uhlig, Inge C Olsen, Anna-Birgitte Aga, Siri Lillegraven, Tore K Kvien and Espen A. Haavardsholm, Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
Background/Purpose: The Patient Reported Outcomes Measurement Information System (PROMIS) initiative has developed and calibrated item banks for the assessment of physical function and other domains…
Abstract Number: 95 • 2016 ACR/ARHP Annual Meeting
An Analysis of Malpractice Litigation in Rheumatology
Arpan Prabhu¹, Raghav Gupta², Ranjit Thomas³ and Chester V. Oddis⁴, ¹University of Pittsburgh School of Medicine, Pittsburgh, PA, ²Rutgers New Jersey Medical School, Newark, NJ, ³Tufts University, Medford, MA, ⁴Rheumatology/Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Medicine is an increasingly more litigious environment, and the probability of a practitioner facing a medical malpractice claim is high. Given the tumultuous liability…
Abstract Number: 96 • 2016 ACR/ARHP Annual Meeting
Transforming Healthcare in Rheumatology: From Inpatient to Outpatient Care without Reductions in Healthcare Quality
Andreas P Diamantopoulos^1,2 and Timothy T Brown¹, ¹Public Health, University of California, Berkeley, Berkeley, CA, ²Rheumatology, Haugesund Hospital for Rheumatic Diseases, Haugesund, Norway
Background/Purpose: The implementation of a major program to improve the quality of care in inflammatory arthritides (rheumatoid arthritis-RA, spondyloarthritis- SpA and psoriatic arthritis- PsA) included…
Abstract Number: 97 • 2016 ACR/ARHP Annual Meeting
Effects of DMARD Tapering on Treatment Costs and Work Productivity in Rheumatoid Arthritis Patients- an Analysis from the Prospective Randomized Controlled Retro- Study
Melanie Hagen¹, Camille P Figueiredo², Jayme Fogagnolo Cobra³, Judith Haschka⁴, Michaela Reiser⁵, Matthias Englbrecht⁶, Axel J. Hueber⁷, Bernhard Manger⁶, Arnd Kleyer⁸, Stephanie Finzel⁹, Hans-Peter Tony¹⁰, Stefan Kleinert¹¹, Joerg Wendler¹², Florian Schuch¹², Monika Ronneberger¹², Martin Feuchtenberger¹³, Martin Fleck¹⁴, Karin Manger¹⁵, Wolfgang Ochs¹⁶, Matthias Schmitt-Haendle¹⁷, H.-M. Lorenz¹⁸, HG Nüßlein¹⁹, R Alten²⁰, Joerg C. Henes²¹, Klaus Krüger²², Georg Schett⁷ and Juergen Rech⁷, ¹Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany, ²Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, ³Instituto de Reumatologia de Sao Paolo, Sao Paolo, Brazil, ⁴Medical Department II, St. Vincent Hospital, the VINFORCE Study Group, Academic Teaching Hospital of Medical University of Vienna, Vienna, Austria, Vienna, Austria, ⁵Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, ⁶Department of Internal Medicine 3, Rheumatology & Clinical Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, ⁷Department of Internal Medicine 3 – Rheumatology and Immunology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, ⁸Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, ⁹Rheumatology and Clinical Immunology, University Medical Center Freiburg, Freiburg, Freiburg, Germany, ¹⁰Rheumatology/Immunology, Medical Clinic II, University Clinic Wuerzburg, Würzburg, Germany, ¹¹Rheumatologische Schwerpunktpraxis Erlangen, Erlangen, Germany, ¹²Schwerpunktpraxis Rheumatologie, Erlangen, Germany, ¹³Rheumatologie/Klinische Immunologie, Kreiskliniken Altötting-Burghausen, Burghausen, Germany, ¹⁴Department of Internal Medicine I, University of Regensburg, 93042 Regensburg, Germany, ¹⁵Rheumatology Practice Bamberg, Bamberg, Germany, ¹⁶Internistisch-rheumatologische Praxisgemeinschaft Bayreuth, Bayreuth, Germany, ¹⁷Rheumatology Practice, Bayreuth, Germany, Bayreuth, Germany, ¹⁸Im Neuenheimer Feld 41, UNI-Klinikum Heidelberg, Medizinische Klinik,, Heidelberg, Germany, ¹⁹University of Erlangen, Nürnberg, Germany, ²⁰Rheumazentrum Ruhrgebiet, Herne, Germany, ²¹Department of Internal Medicine II, Division of Rheumatology, University Hospital Tuebingen, Tuebingen, Germany, ²²Praxiszentrum St. Bonifatius, München, Germany
Effects of DMARD Tapering on Treatment Costs and Work Productivity in Rheumatoid Arthritis Patients- an Analysis from the Prospective Randomized Controlled RETRO- Study Background/Purpose: Achieving remission…
Abstract Number: 98 • 2016 ACR/ARHP Annual Meeting
Daily Symptom Reports in a Smartphone-Based Study ‘Cloudy with a Chance of Pain’: Patterns of Attrition over the First Six Months
Katie Druce¹, Sabine N van der Veer², Mohammed A Chowdhury¹, John McBeth³, Jamie C Sergeant¹, Rikesh Patel³ and William G Dixon⁴, ¹Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, ²Health e-Research Centre, University of Manchester, Manchester, United Kingdom, ³Manchester Academic Health Science Centre, Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, ⁴Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, Great Britain
Background/Purpose: The increasing uptake of smartphones and health apps provides opportunities for epidemiological studies to collect regular information from large numbers of people. This offers…
Abstract Number: 99 • 2016 ACR/ARHP Annual Meeting
Academic and Non-Academic Rheumatology: Practice Trends and Common Barriers to Practice from the 2015 ACR/ARHP Workforce Study Survey
Seetha Monrad¹, Daniel Battafarano² and Marcia Ditmyer³, ¹Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI, ²Medicine, San Antonio Military Medical Center, San Antonio, TX, ³Academy for Academic Research, Las Vegas, NV
Background/Purpose: Ten years have elapsed since the last ACR workforce study (WFS), and it is anticipated that rheumatologists will face many challenges to train and…
Abstract Number: 100 • 2016 ACR/ARHP Annual Meeting
Patient Support Program for Adalimumab-Treated Patients in Brazil: Impact on Patients’ Adherence and Persistence
Roger A. Levy¹, Vanessa Teich², Roberta Fernandes², Anna Gulart², Leonardo Chaves³, Vishvas Garg⁴ and Martha Skup⁵, ¹Rheumatology, Department of Rheumatology, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, ²Sense Company, São Paulo, Brazil, ³AbbVie Inc., Chicago, IL, ⁴AbbVie Inc, North Chicago, IL, ⁵AbbVie Inc., North Chicago, IL
Background/Purpose: The Brazilian public healthcare system covers treatment with adalimumab for rheumatoid arthritis, Crohn's disease, ankylosing spondylitis and psoriatic arthritis, in line with local guidelines.…
Abstract Number: 101 • 2016 ACR/ARHP Annual Meeting
Rheumatology Care Utilization and Geographic Distance from Rheumatology Sites within the United States Veteran Affairs Health Care System
Jessica A. Walsh¹, Zachary Burningham², Chia-Chen Teng, MS³, Daniel O. Clegg⁴ and Brian C. Sauer, PhD³, ¹University of Utah School of Medicine, Salt Lake City, UT, ²SLC Veterans Affairs Medical Center, SLC IDEAS Center, Salt Lake City, UT, ³Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ⁴Division of Rheumatology, University of Utah Medical Center, Salt Lake City, UT
Background/Purpose: Within the Veteran Affairs (VA) health care system, there are often large geographic distances between patients and rheumatology providers. The purpose of this study…
Abstract Number: 102 • 2016 ACR/ARHP Annual Meeting
The 2015 American College of Rheumatology (ACR) Workforce Study: A Snapshot of Academic Division Directors
Marisa S. Klein-Gitelman¹, Daniel Battafarano², Seetha Monrad³ and Marcia Ditmyer⁴, ¹Div of Pediatric Rheumatology/PDD PTD, Lurie Children's Hospital of Chicago/NW University, Chicago, IL, ²Medicine, San Antonio Military Medical Center, San Antonio, TX, ³Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI, ⁴Academy for Academic Research, Las Vegas, NV
Background/Purpose: The ACR has engaged in workforce studies as a mechanism to address ongoing and future needs of college members. In order to address needs…
Abstract Number: 103 • 2016 ACR/ARHP Annual Meeting
People with Rheumatoid Arthritis Recruited from an Online Patient Community May Differ from Clinical Populations in Symptoms and Impacts
Anna Kristina Gutierrez¹, Susan J. Bartlett^1,2, Michelle Jones³, W. Benjamin Nowell⁴, Seth D. Ginsberg⁴, Vivian P. Bykerk⁵, Jeffrey R. Curtis⁶ and Clifton Bingham III⁷, ¹Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Global Healthy Living Foundation, CreakyJoints, Upper Nyack, NY, ⁵Divison of Rheumatology, Hospital for Special Surgery, New York, NY, ⁶Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁷Johns Hopkins University, Baltimore, MD
Background/Purpose: Patients are increasingly recruited from online communities to provide insight regarding their lived experiences and preferences for treatment and services. We compared physical, social,…
Abstract Number: 104 • 2016 ACR/ARHP Annual Meeting
Incremental Direct Expenditures Due to Osteoarthritis: A Nationally Representative Study Using Medical Expenditure Panel Survey Data
Jyothi Menon, Purdue University, West Lafayette, IN
Background/Purpose: Osteoarthritis is characterized by symptoms related to abnormalities in joints, subchondral bones and periarticular structures. In the United States, it was estimated that twenty-seven…
Abstract Number: 105 • 2016 ACR/ARHP Annual Meeting
Regional Primary Care Rheumatology Networks for Patients with Rheumatic and Musculoskeletal Diseases: Need for a National Approach
Wilfred Peter¹, Florus van der Giesen², Cornelia H.M. van den Ende³, Joost Dekker⁴ and Thea P. M. Vliet Vlieland⁵, ¹Orthopeadics, Rehabilitation and Physical Therapy, Leids University Medical Center, Leiden, Netherlands, ²Orthopaedics, Rehabilitations and Physical Therapy, Leiden University Medical Centre, Leiden, Netherlands, ³Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, ⁴Rehabilitation Medicine, VU University Medical Center, Amsterdam, Netherlands, ⁵Orthopaedics, Rehabilitation and Physical Therapy, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Regional primary care rheumatology networks of health professionals (HPs) are instituted to improve the quality of care for patients with rheumatic and musculoskeletal diseases…
Abstract Number: 106 • 2016 ACR/ARHP Annual Meeting
Patient Satisfaction Survey of a Newly Set up Physiotherapist Lead Axial Spondyloarthritis Clinic
Clare Longton¹, Marco Massarotti² and Marwan Bukhari³, ¹Rheumatology, Royal Lancaster Infirmary, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom, ²Rheumatology, Royal Lancaster Infirmary, University Hospital of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom, ³Royal Lancaster Infirmary, Lancaster, United Kingdom
Background/Purpose: Present guidelines (National Institute for Health and Care Excellence- NICE technology appraisal guidance TA143 2008 and TA233 2011; National Ankylosing Spondylitis Society 2010) on…
Abstract Number: 107 • 2016 ACR/ARHP Annual Meeting
Improvement of Quality and Cost-Effectiveness of Rheumatology Care By Creating Long-Term Alliances with Pharmaceutical Companies
M Van Houdenhoven (CEO, PhD, Prof)¹, F.H.J. van den Hoogen (MD, PhD, Prof)², K Bevers (MD, PhD)², W.H. van der Laan (MD, PhD)², J Van der Werf², M Staub³ and B.J.F. Van den Bemt (PharmD, PhD)⁴, ¹Sint Maartenskliniek, Nijmegen, Netherlands, ²Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, ³Purchasing department, Sint Maartenskliniek, Nijmegen, Netherlands, ⁴Department of Pharmacy, Sint Maartenskliniek, Nijmegen, Netherlands
Background/Purpose: Biological therapies have importantly contributed to controlling disease activity in patients with inflammatory rheumatic diseases. As the high costs of biologics are a threat…
Abstract Number: 108 • 2016 ACR/ARHP Annual Meeting
Does Receiving Physical Therapy for Knee Osteoarthritis Impact Downstream Healthcare Utilization?
Allyn Bove¹, Christopher Bise¹, Ken Smith², Julie Fritz³, John Childs⁴, Gerard P. Brennan⁵, J. Haxby Abbott⁶ and G. Kelley Fitzgerald⁷, ¹Physical Therapy, University of Pittsburgh, Pittsburgh, PA, ²Division of Internal Medicine; Institute for Clinical Research Education, University of Pittsburgh, Pittsburgh, PA, ³Department of Physical Therapy, University of Utah, Salt Lake City, UT, ⁴US Army-Baylor University, Schertz, TX, ⁵Rehabilitation Services, Intermountain Healthcare, Murray, UT, ⁶Centre for Musculoskeletal Outcomes Research, Department of Surgical Sciences, University of Otago, Dunedin, New Zealand, ⁷Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: The clinical effectiveness of supervised exercise therapy for individuals with knee osteoarthritis (KOA) is well known. However, it is unclear whether participation in a…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].